INDRAMEDCOBSEIndraprastha Medical Corporation LtdMediumNeutral
Announced Wed, 27 May · 15:11 IST

we wish to inform you that ICRA Limited has vide its letter dated 26th May, 2026, re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation ....

Credit & Debt View source PDF

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹373.60
prior close
₹390.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.2+0.4+2.4+0.1+0.1+7.1+7.6+3.9+1.5+1.7-1.2
Up moveDown movePending
AI summary

ICRA Limited has re-affirmed Indraprastha Medical Corporation's credit ratings with the long-term rating maintained at [ICRA]AA(Stable) and short-term rating at [ICRA]A1+. The total rated facilities amount to Rs. 162.50 crore, comprising Rs. 92.50 crore term loans, Rs. 40 crore cash credit, and Rs. 30 crore short-term non-fund based facilities. The re-affirmation indicates ICRA sees no material change in the company's creditworthiness or debt servicing capability since the last rating exercise.

Likely market impact

The re-affirmation of high-grade ratings is positive for shareholders as it signals the company's continued financial stability and low credit risk. This should support investor confidence in the company's debt obligations and financial health.